SEC Contract Filing

Filing Date: 2019-10-29

Document Content:
<DOCUMENT>
<TYPE>EX-10.2.1
<SEQUENCE>5
<FILENAME>incy-20190930ex1021f3558.htm
<DESCRIPTION>EX-10.2.1
<TEXT>
<!--HTML document created with Toppan Merrill Bridge 9.4.0.81-->
<!--Created on: 10/29/2019 6:31:55 PM-->
<html>
	<head>
 <title>
 incy_Ex_10_2_1
 </title>
	</head>
	<body><div style="margin-left:4.41176470588235%;margin-right:4.41176470588235%;"></div><div style="margin-left:4.41176470588235%;margin-right:4.41176470588235%;">
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;text-align:right;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-size:12pt;">Exhibit&nbsp;10.2.1</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;font-weight:bold;font-style:italic;font-size:12pt;">EXTENSION OF CONFIDENTIAL TREATMENT REQUESTED:&nbsp; Certain identified information, marked by [***], has been excluded from the exhibit because it is both (i) not material and (ii) would likely cause competitive harm to the Company, if publicly disclosed.&nbsp; An extension of confidential treatment for such information has been requested.&nbsp; An unredacted version of this document has been filed separately with the Securities and Exchange Commission (the &#x201C;Commission&#x201D;).</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 11pt;">
 <font style="display:inline;font-size:11pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">AMENDMENT</font>
 </p>
 <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">This Amendment (&#x201C;Amendment&#x201D;) is entered into effective June 22, 2010 (the &#x201C;Amendment Effective Date&#x201D;) by and between Incyte Corporation,&nbsp;&nbsp;a Delaware Corporation having an office at Experimental Station, Route 141 &amp; Henry Clay Road, Wilmington, Delaware (&#x201C;Incyte&#x201D;), and Eli Lilly and Company (&#x201C;Lilly&#x201D;), an Indiana corporation having an office at Lilly Corporate Center, Indianapolis, Indiana 46285.</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">RECITALS</font>
 </p>
 <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">A.&nbsp;&nbsp;&nbsp;Incyte and Lilly are parties to a License, Development and Commercialization Agreement (&#x201C;Agreement&#x201D;), effective December 18, 2010 (&#x201C;Effective Date&#x201D;)&nbsp;&nbsp;&nbsp;pursuant to which Incyte has granted Lilly an exclusive license to develop and commercialize Licensed Compounds and Licensed Products in the Field.</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">B.&nbsp;&nbsp;&nbsp;The parties now desire to amend the Agreement to </font><font style="display:inline;font-family:Times New Roman,Times,serif;font-size:12pt;">[***].</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">C.&nbsp;&nbsp;&nbsp;Unless otherwise defined herein, all capitalized terms appearing in this Amendment shall have the meaning as set forth in the Agreement.</font>
 </p>
 <p style="margin:0pt 0pt 0pt 36pt;text-indent: -18pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;text-align:center;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">AGREEMENT</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-family:Times New Roman,Times,serif;color:#000000;font-size:12pt;">The parties hereby agree as follows:</font>
 </p>
 <p style="margin:0pt;font-family:Times New Roman,Times,serif;font-size: 12pt;">
 <font style="display:inline;font-size:12pt;">&nbsp;</font>
 </p>
 <p style="mar